StockData
STVNNYSESurgical & Medical Instruments & Apparatus

Stevanato Group S.p.A.

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 4, 2026
$19.02+0.12 (+0.63%)

Close on Oct 19, 2026

Stevanato Group S.p.A. income statement

Ratios

Latest available, balances at Dec 31, 2025

Profitability, FY2025

Gross margin
29.0%
Operating margin
16.8%
Net margin
11.8%
Return on equity, FY2025
9.7%

Financial strength

Current ratio
1.76
Debt to equity
–
Debt to assets
–
Cash to current liabilities
24.4%

Valuation

P/E ratio
–
Price to sales
–
Price to book
–
Dividend yield
–

Valuation ratios need the share price and fill in once daily prices are connected.